Literature DB >> 11682035

Cloning and characterization of the 5'-flanking region of human cytokeratin 19 gene in human cholangiocarcinoma cell line.

M Kagaya1, S Kaneko, H Ohno, K Inamura, K Kobayashi.   

Abstract

BACKGROUND/AIMS: The regulatory mechanism of cell-specific gene expression in cholangiocytes has not been sufficiently evaluated. In this study, we characterized the 5'-flanking region of the cytokeratin 19 gene expressed specifically in cholangiocytes.
METHODS: We cloned a 2952-bp fragment in the 5'-flanking region of cytokeratin 19 and evaluated the regulatory mechanism of gene expression in this region by assaying transient expression of reporter gene and DNA footprinting.
RESULTS: This segment of the 5'-flanking region of the human cytokeratin 19 gene shows an intense transcriptional activity in the cholangioma cell line KMBC, which was about 10 times its activity in the osteosarcoma cell line Saos-2, which does not express cytokeratin 19. From the results of reporter assays, important transcription regulatory elements are considered to be located in the segments from -2249 to -2050 bp and from -732 bp to the first ATG, and six protein-binding sites were detected in the segment from -732 bp to the first ATG by the DNA footprinting technique.
CONCLUSIONS: Sp1 site, CCAAT box, and TATA box were present in the segment from -374 to the first ATG, and they are considered to constitute a cholangiocyte-specific promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682035     DOI: 10.1016/s0168-8278(01)00167-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Evaluation of promoters for use in tissue-specific gene delivery.

Authors:  Changyu Zheng; Bruce J Baum
Journal:  Methods Mol Biol       Date:  2008

3.  High promoter activity of cytokeratin-19 gene in cholangiocarcinoma.

Authors:  Jian Qin; Min Wang; Jun Qin; Qu Cai; Zhi-Hai Peng
Journal:  Mol Clin Oncol       Date:  2018-08-16

4.  A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1.

Authors:  Masayuki Shimoda; Shuyuan Chen; Hirofumi Noguchi; Morihito Takita; Koji Sugimoto; Takeshi Itoh; Daisuke Chujo; Shuichi Iwahashi; Bashoo Naziruddin; Marlon F Levy; Shinichi Matsumoto; Paul A Grayburn
Journal:  Hum Gene Ther Methods       Date:  2014-06       Impact factor: 2.396

5.  Comprehensive Analysis of the Potential Immune-Related Biomarker ATG101 that Regulates Apoptosis of Cholangiocarcinoma Cells After Photodynamic Therapy.

Authors:  Zi-Jian Zhang; Kun-Peng Wang; Yun-Peng Huang; Chong Jin; Hao Jiang; Li Xiong; Zhao-Yi Chen; Yu Wen; Zhong-Tao Liu; Jing-Gang Mo
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

6.  Identification of keratin 19-positive cancer stem cells associating human hepatocellular carcinoma using CYFRA 21-1.

Authors:  Takayuki Kawai; Kentaro Yasuchika; Takamichi Ishii; Hokahiro Katayama; Elena Yukie Yoshitoshi; Satoshi Ogiso; Takahito Minami; Yuya Miyauchi; Hidenobu Kojima; Ryoya Yamaoka; Sadahiko Kita; Katsutaro Yasuda; Naoya Sasaki; Ken Fukumitsu; Etsuro Hatano; Shinji Uemoto
Journal:  Cancer Med       Date:  2017-09-30       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.